NeOnc Technologies Holdings is trading at $3.00, up 7.91%, with no direct catalyst established for its pre-market move.

  • No company-specific announcement was found for October 12; NeOnc’s latest investor-relations release was September 17.
  • Biotech strength in the prior session offers context, but the biotech ETF was little changed pre-market October 12 and does not clearly explain the gain.